Economic Impact
Pharmaceuticals are high-tech, high-risk, high-investment, high-return industries, which have always been the focus of competition in developed countries, and with the development of economic globalization, the international competition is becoming increasingly fierce. In order to enhance the international competitiveness of multinational corporations, through large-scale unions and mergers and international capital market operations, the establishment of global production and sales network, expanding market share. The influence of multinational corporations on the world economy is getting bigger and bigger, which makes the competitors of China's pharmaceutical industry become stronger than ever. The internationalization of the domestic market and stricter protection of intellectual property rights have made market competition more direct and life-and-death. The worldwide economic restructuring has made developing countries such as India a strong competitor for China.
2. The rapid development of modern biotechnology.
The rapid development of modern biotechnology will have a revolutionary impact on the pharmaceutical industry, the deepening of the understanding of difficult diseases, many new biotechnology drugs, biotechnology to transform traditional industries will greatly change the face of the pharmaceutical industry. The world's developed countries to take advantage of capital, technology, market advantages, the implementation of monopoly, China's medicine will be in the field of biotechnology with the developed countries to start a new round of competition.
3. Natural medicine boom.
With the rise of the trend of return to nature, the international market demand for natural medicine is increasing. World plant products sales of nearly 30 billion U.S. dollars, of which the sales of natural medicines has reached 16 billion U.S. dollars, and 10% annual rate of increase. For this reason, countries are competing to use modern technology research and development of traditional medicine, to seize the international natural medicine market. This provides an opportunity for China's traditional Chinese medicine to develop the international market. The international market
In 1996 and 1999, the annual growth of the world drug market was about 5.5%, and the global drug sales in 2000 were about 368 billion U.S. dollars. Although governments are controlling the growth of pharmaceutical costs, but due to the development of new drugs, demographic changes and people's health expectations, the pharmaceutical market growth is still faster than the rate of economic growth, is expected to the next five years will be 8% of the rate of growth, in 2005 will reach about 540 billion U.S. dollars. Statistical analysis, the orientation and trend of the future development of the international pharmaceutical market can be summarized as the following five:
(1) all developed countries (and a few developing countries) the population is aging, the demand for therapeutic drugs suitable for the characteristics of the diseases of the aging population increases;
(2) due to the high cost of inpatient medical care, wherever it is possible to shorten the hospitalization days, in particular, to change the inpatient treatment for the outpatient treatment have excellent prospects for development. Controlled and slow-release drugs that can improve bioavailability and ease of administration will be further developed;
(3) With the development of society and the influence of the environment and the change of the disease spectrum, some medical fields are still lacking in high-efficiency and effective drugs, which provides an opportunity for the creation of new medicines;
(4) The development of biotechnology and the wide application of biotechnology in the field of pharmaceuticals will lead to effective treatments for many difficult diseases, and it is expected that the core of genetic engineering will be used to create new drugs and new drugs. It is expected that therapeutic biopharmaceuticals, diagnostic reagents and vaccines centered on genetic engineering will develop rapidly and gradually expand their share in the world pharmaceutical market;
(5) generic drugs will grow steadily, and preventive medicines and healthcare-related products will receive more attention. China's pharmaceutical market in addition to the impact of the international market, but also by the following changes in the domestic environment and constraints:
(1) the population's living standards. The United States and other developed countries per capita annual drug consumption of about 300 U.S. dollars, the average per capita consumption of drugs in medium-developed countries for 40_50 U.S. dollars, while China less than 10 U.S. dollars, which reflects both the gap between China and developed countries in drug consumption, but also reflects the potential for development of China's pharmaceutical market. With the implementation of the third step of China's modernization and construction of strategic objectives, the people's living standards and quality of life, and the updating of the concept of medicine consumption, China's pharmaceutical market growth will be faster than the world's pharmaceutical market growth.
(2) Reform of the medical insurance system is advancing comprehensively. During the Tenth Five-Year Plan period, the reform of China's basic medical insurance system for urban workers will be carried out comprehensively, and the basic principle of this system is low level and wide coverage. Its implementation will, on the one hand, expand the scope of the medical insurance population from 160 million to 300 million, and on the other hand, adjust the unreasonable consumption of medicines, inhibit the use of expensive imported medicines and large-scale medical equipments, and promote the use of inexpensive and efficacious domestically produced generic medicines. Reform of the medical insurance system in general will promote the consumption of pharmaceutical products, thus boosting the growth of the pharmaceutical economy.
(3) The level of urbanization has increased. in 2000, China has 460 million urban population, and with an average annual growth rate of 2.7%, as China's urbanization process continues to advance, during the fifteenth period, the annual increase of about 10 million urban population. China's urban per capita drug consumption and rural drug consumption level ratio of about 7:1, the development of urbanization will increase the demand for pharmaceutical products.
(4) Net population growth. in 2000, China had a population of 1.295 billion, and in 2010 China's population reached 1.339.7 billion. By 2015 China's population will reach 1.33 billion. The net population growth will generate new demand for pharmaceutical products.
(5) Population aging. According to the 2010 census data, China's population aged 60 and above accounted for 13.26%, the aging process is gradually accelerating. It is expected to grow at a faster rate during the 12th Five-Year Plan period. The total amount of medicines for the elderly during the 12th Five-Year Plan period will have a greater growth.
(6) The implementation of the drug classification and management system. With the implementation and further improvement of China's prescription and non-prescription drug system, the retail drug market will further expand, and is expected to grow at an average annual rate of about 15% during the Tenth Five-Year Plan period
(7) The establishment and improvement of the rural cooperative medical system, the strengthening of the three-tiered health prevention network in rural areas, and the increase in farmers' incomes have created room for the development of the pharmaceutical market. During the Tenth Five-Year Plan period, rural drug consumption demand is the main growth point of the pharmaceutical market.